Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 15/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.82 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quinaprilat SCHEMBL11306348 | 1.00 | ACE (1.00) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL29598971 | 1.00 | ACE (1.00) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL11286565 | 1.00 | ACE (1.00) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL11286571 | 1.00 | ACE (1.00) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL7421419 | 1.00 | ACE (1.00) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL113237 | 1.00 | ACE (1.00) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL6438000 | 1.00 | ACE (1.00) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL9253792 | 1.00 | ACE (1.00) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL27697059 | 0.99 | ACE (0.98) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL27717008 | 0.99 | ACE (0.98) | ACEABCB11PDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5225401-A | Endopeptidase inhibitors for congestive heart failure | E. R. SQUIBB & SONS, INC. (US) | 1993-07-06 | — | — | US | disclosed |
| EP-0527624-A2 | Use of a selective inhibitor of neutral endopeptidase and an angiotensin converting enzyme inhibitor in the preparation of a pharmaceutical for treating congestive heart failure | E.R. Squibb & Sons, Inc. (US) | 1993-02-17 | — | — | EP | disclosed |